High-Resolution OCT of Retinal Vessels in Eyes with Vascular Leakage Authors: Francesco Romano, Francesca Lamanna, Mariano Cozzi, Francesco Cutrupi, Pier Luigi Surico, David Sarraf, SriniVas Sadda, Vishali Gupta, Ahmed Abu El Asrar, Luca Cimino, Giovanni Staurenghi, Alessandro Invernizzi Published: 2026 ABSTRACT AbstractPurposeTo identify and compare qualitative and quantitative retinal venous wall alterations associated with fluorescein angiography (FA)–documented vascular leakage in eyes with retinal vein occlusion (RVO) and active uveitis using high-resolution OCT (High-Res OCT), and to assess their longitudinal evolution after uveitis remission.DesignProspective, observational, cross-sectional and longitudinal study.ParticipantsTwenty-nine eyes from 25 adults with FA-confirmed perivenular leakage due to new-onset RVO (16 eyes) or active uveitis (13 eyes). A subset of uveitis eyes underwent follow-up imaging after clinical remission.MethodsHigh-resolution OCT line scans were acquired longitudinally along leaking retinal veins. Qualitative features (wall splitting, outer fuzziness, hyporeflective spaces) and quantitative metrics (lumen diameter, inner and outer vessel wall thickness, and overlying inner retinal layer thickness) were assessed and compared between RVO and uveitis and against age-, sex-, and laterality-matched healthy control vessels. Longitudinal changes were analyzed in uveitis eyes after remission.Main Outcome MeasuresHigh-resolution OCT qualitative features and quantitative measurements of retinal venous wall and perivascular structure.ResultsForty leaking retinal veins (21 RVO, 19 uveitis) were analyzed. Eyes with RVO demonstrated greater lumen diameter (median, 180 μm vs. 122 μm; P < 0.001), increased inner retinal thickness, and hyporeflective inner retinal spaces, without significant outer wall involvement. In contrast, uveitis eyes showed greater outer wall thickness (median, 16.5 μm vs. 11.0 μm; P = 0.001), frequent outer fuzziness (89.5%), and wall splitting (37.5%), without luminal enlargement. Compared with matched healthy controls, RVO vessels exhibited increased lumen diameter, whereas uveitis vessels showed selective outer wall thickening. In longitudinal uveitis analysis, outer wall thickening and wall splitting resolved after remission, while outer fuzziness partially persisted.ConclusionsHigh-resolution OCT identified different patterns of retinal venous wall involvement associated with vascular leakage in eyes with RVO and uveitis. These findings support further evaluation of High-Res OCT as an imaging modality for characterizing retinal vascular leakage and monitoring inflammatory disease activity.Financial DisclosuresProprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.Keywords: High-resolution OCT, Vasculitis, Vascular leakage, Retina vein occlusion, Retina vessels The inner blood–retinal barrier (iBRB) plays a critical role in preserving retinal homeostasis by regulating the exchange of solutes, nutrients, and immune cells between the circulation and retinal tissue. This selective permeability is maintained by a neurovascular unit comprising endothelial tight junctions, basement membrane components, pericytes, and supportive glial elements such as Müller cells.1 Disruption of these mechanisms compromises barrier integrity, leading to vascular leakage and inflammation—hallmarks of retinal vascular diseases including retinal vein occlusion (RVO) and uveitis.2 Historically, evaluation of iBRB integrity has relied on fluorescein angiography (FA), which remains a cornerstone for detecting early or subtle vascular abnormalities, particularly when funduscopic changes are minimal. Although FA provides dynamic information regarding leakage, it lacks the spatial resolution necessary to delineate the structural features of retinal vessels responsible for barrier breakdown.3 Importantly, structural correlates of FA-detected leakage on OCT remain poorly defined. OCT has revolutionized retinal imaging by enabling high-resolution, cross-sectional visualization of the neurosensory retina and its vasculature.4 Prior studies have characterized retinal vessels qualitatively and quantitatively, identifying the peripapillary B zone (0.5-1.0 disc diameters from the optic nerve head)5 and longitudinal scan orientation as the most reproducible regions for vessel wall assessment.6, 7, 8 However, consistent delineation of the inferior vessel wall remains challenging due to shadowing and signal attenuation.8,9 More recently, a prototype high-resolution OCT system (High-Res OCT; Heidelberg Engineering) has been introduced, leveraging a shorter central wavelength and broader bandwidth to enhance axial resolution and improve visualization of vascular anatomy and subtle pathological changes.10, 11, 12, 13, 14, 15, 16 High-resolution OCT angiography has further refined understanding of venous outflow from the deep capillary plexus and vascular interconnections.17,18 These features may help distinguish structural vessel wall changes in conditions such as RVO and retinal vasculitis, which often share similar FA leakage patterns but arise from distinct pathophysiological mechanisms. The aim of this study was to evaluate qualitative and quantitative biomarkers of retinal venous wall alterations in eyes with FA-documented vascular leakage due to new-onset RVO or active uveitis using High-Res OCT. In a subset of uveitis eyes, follow-up imaging was performed 3 months after clinical remission to assess the potential of these parameters as longitudinal biomarkers. Methods Design and Participants This prospective, observational, cross-sectional, and longitudinal study was conducted at the Eye Clinic of Ospedale Luigi Sacco (University of Milan, Milan, Italy) between January and November 2024. The study adhered to the Declaration of Helsinki and Italian bioethics regulations and was approved by the Institutional Ethics Committee of the University of Milan (Protocol No. 19.22). Written informed consent was obtained from all participants. Eligible participants were consecutive adults (>18 years) with either (a) active posterior, intermediate, or panuveitis, or (b) treatment-naïve new-onset central or branch RVO, presenting with same-day FA evidence of perivenular leakage involving the first 3 branches of the central retinal vein and baseline best-corrected visual acuity better than 20/200 Snellen equivalent. The exclusion criteria included insufficient image quality, significant media opacities (e.g., dense cataract, vitreous hemorrhage, and severe vitritis), refractive error exceeding ±6 diopters, confounding retinal diseases (except mild hypertensive retinopathy in RVO), recent use of retinotoxic drugs, or history of ocular surgery within the previous 6 months. Both eyes were included when eligible. Study Protocol At baseline, all participants underwent standardized ophthalmic examination including detailed medical history collection, best-corrected visual acuity assessment using the ETDRS chart, slit lamp biomicroscopy with Goldmann applanation tonometry, color fundus photography (EIDON; CenterVue/iCare), FA (55° × 55° and 30° × 30°), 30° × 25° macular OCT (Spectralis HRA + OCT2; Heidelberg Engineering GmbH), and High-Res OCT line scans aligned longitudinally to leaking retinal veins. Indocyanine green angiography was performed in uveitis cases as clinically indicated. Clinical management was determined by a single senior consultant (A.I.). Eyes with RVO were managed with intravitreal anti-VEGF therapy, observation, and/or retinal photocoagulation based on macular edema and retinal ischemia. Uveitis cases underwent etiologic evaluation and guideline-based therapy including systemic corticosteroids, immunosuppressive agents, antibiotics, or combinations thereof. In eyes with uveitis achieving clinical remission, follow-up High-Res OCT imaging was performed at 3 months using automated scan registration to reassess the same vascular segments. Longitudinal High-Res OCT analysis was not feasible in most RVO eyes because the marked posttreatment changes in venous caliber and tortuosity prevented reliable tracking of the same vascular segment. Demographic and clinical data extracted from medical records included age, sex, race/ethnicity (White non-Hispanic vs. Other), eye laterality, cardiovascular comorbidities, best-corrected visual acuity, and administered ocular and systemic treatments. High-Res OCT Imaging Protocol and Analysis The High-Res OCT system (Heidelberg Engineering), introduced in March 2021 as an investigational platform, provides enhanced axial resolution (<3 μm) while maintaining lateral resolution comparable to the standard SPECTRALIS OCT2 system. This improvement is enabled by expanding the spectral bandwidth from 50 to 137 nm via 3 superluminescent diodes and shifting the central wavelength from 880 to 853 nm. To compensate for the signal-to-noise ratio reduction inherent to broader bandwidths, the incident light power at the corneal surface was increased from 1.2 to 2.2 mW. Preliminary studies have demonstrated significantly higher measurement precision and repeatability of individual retinal layers with High-Res OCT compared to conventional spectral-domain OCT.19,20 All eligible patients with active uveitis or RVO were screened by a single retina and uveitis specialist (A.I.) to identify retinal veins with late-phase perivascular leakage on FA within the first 3 branches of the central retinal vein. Same-day High-Res OCT imaging was performed by a certified photographer (M.C.). For each leaking vein, a 10° single-line scan was acquired longitudinally along the vessel axis using automated real-time tracking (100-frame averaging). At least 3 scans per vessel were obtained, and the scan with optimal visualization of both vessel walls was selected. Up to 2 vessels per eye were included. Two fellowship-trained graders (F.R. and F.L.), masked to the formal clinical diagnosis and patient records, independently evaluated at baseline all selected scans using Heidelberg Eye Explorer software (HEYEX, version 1.10.4.0). Qualitative disagreement and quantitative discrepancies >10% were adjudicated by a senior grader (A.I.). Qualitative features included (1) vessel wall visibility, defined as clear delineation of the inner and outer venous wall contours; (2) wall splitting, an apparent intramural separation of the vessel wall by an intervening hyperreflective fuzzy material; (3) outer fuzziness, contiguous ill-defined hyperreflective material immediately external to the outer venous wall, causing blurring of the normal outer vessel boundary relative to adjacent retinal tissue; and (4) hyporeflective spaces, perivascular cystic-appearing hyporeflective changes near the inner or outer wall. Quantitative measurements (μm) included (1) lumen thickness; (2) inner and (3) outer wall thickness; and (4) overlying inner retinal layer (IRL) thickness. All measurements were obtained at a standardized point located 1000 μm from the optic disc margin (≈0.67 disc diameters), but only after the analyzed vein had been identified on FA as a leaking vessel and scanned longitudinally with High-Res OCT. This peripapillary B zone location (0.5-1.0 disc diameter) was selected to maximize vessel wall delineation and measurement reproducibility across eyes. For each vein, ≥3 longitudinal scans were acquired along the vessel axis, and the scan selected for analysis was the one showing the clearest simultaneous delineation of both vessel walls, in order to minimize off-axis sectioning artifacts. Because thicknesses were measured axially on OCT B-scans, axial length correction was not applied. In eyes with uveitis, identical assessments were repeated at 3 (±1) months after clinical remission and resolution of FA leakage. Representative examples are shown in Figure 1. Qualitative and quantitative biomarkers assessed on High-Resolution OCT (Heidelberg Engineering GmbH). Left panels show representative B-scans illustrating the qualitative parameters evaluated, including: visibility of the outer wall (yellow arrowheads), sharp delineation of the external venous wall contour; “wall splitting” sign (orange arrowheads), apparent intramural separation within the venous wall; outer fuzziness (green arrowheads), contiguous ill-defined hyperreflective material external to the outer venous wall, blurring the normal vessel boundary; hyporeflective spaces (blue arrowheads), perivascular cystic-appearing hyporeflective changes. Right panel illustrates the quantitative measurements performed on High-Resolution OCT scans, obtained 1000 μm from the optic disc margin in the peripapillary B-zone. Color-coded calipers represent inner retinal layer thickness (yellow), inner wall thickness (orange), lumen diameter (green), and outer wall thickness (blue). Statistical Analysis All analyses were performed using R Studio (version 2023.12.0+369; RStudio, PBC). All tests were 2-sided, with statistical significance set at P < 0.05. Normality was assessed using the Shapiro–Wilk test. Continuous variables are reported as mean ± standard deviation or median (interquartile range), as appropriate, and categorical variables as counts and percentages. Based on unpublished normative data, a priori power analysis (α = 0.05; power = 80%) estimated that ≥19 vessels per group were required to detect clinically meaningful differences in vessel wall and lumen thickness. Between-group comparisons (RVO vs. uveitis) and within-group longitudinal comparisons were performed using unpaired and paired Student t-tests, respectively. Categorical variables were analyzed using Pearson chi-square or Fisher exact test, as appropriate. Intergrader agreement was assessed using Cohen κ for categorical variables and 2-way mixed-effects intraclass correlation coefficients for continuous measures. To account for multiple vessels per eye and inclusion of both eyes from the same patient, generalized linear mixed-effects models were fitted for each quantitative OCT parameter, including diagnosis group as a fixed effect, age, sex, and cardiovascular risk factors as covariates, and patient and eye as random intercepts. Results are reported as β coefficients with 95% confidence intervals. For normative comparisons, control vessels were selected from an internal healthy cohort using propensity score matching based on age, sex, and eye laterality. Comparisons among RVO, uveitis, and control groups were performed using the Kruskal–Wallis test with Dunn post hoc analysis and Benjamini–Hochberg correction. Results Of the 43 eyes initially screened, 29 eyes from 25 patients were included: 16 eyes with RVO-related (55.2%) and 13 with uveitis-related (44.8%) vascular leakage. Exclusions were due to absence of focal perivenular leakage within the first 3 venous branches (n = 10) or insufficient OCT image quality (n = 4). Representative multimodal imaging examples are shown in Figure S1 (available at www.ophthalmologyscience.org). Patients with RVO were significantly older than those with uveitis (66.9 ± 13.4 vs. 40.7 ± 16.3 years; P < 0.001). No differences were observed in sex (P = 0.45) or race/ethnicity (P = 0.13), whereas cardiovascular risk factors were more frequent in the RVO group (P = 0.02). Intergrader agreement was substantial to excellent for categorical variables (Cohen κ: 0.75-0.87) and good to excellent for continuous measures (intraclass correlation coefficient: 0.813-0.921). Baseline characteristics are summarized in Table 1. Table 1Clinical and Demographic Features of the Study CohortsRetinal Vein OcclusionUveitisCohort Patients, n (%)14(56.0%)11(44.0%) Eyes, n (%)16(55.2%)13(44.8%) Vessels, n (%)21(52.5%)19(47.5%)Age (years) Mean (SD)66.9(13.4)40.7(16.3)Sex Male, n (%)9(64.3%)6(54.5%) Female, n (%)5(35.7%)5(45.5%)Race/ethnicity White non-Hispanic, n (%)12(85.7%)6(54.5%) Other, n (%)2(14.3%)5(45.5%)SubgroupsBRVO, n (%)9Toxoplamosis, n (%)5CRVO, n (%)7Sarcoidosis, n (%)4Other, n (%)4% = percentage; BRVO = branch retinal vein occlusion; CRVO = central retinal vein occlusion; n = frequency; SD = standard deviation. Clinical and Demographic Features of the Study Cohorts % = percentage; BRVO = branch retinal vein occlusion; CRVO = central retinal vein occlusion; n = frequency; SD = standard deviation. Vascular Differences between RVO and Uveitis Forty leaking retinal veins were analyzed (21 RVO, 19 uveitis). The inner vessel wall was visualized in all cases, and outer wall visibility was comparable between groups (RVO 85.7% vs. uveitis 84.2%). Outer fuzziness was significantly more frequent in uveitis (89.5% vs. 4.8%; P < 0.001), and wall splitting was observed exclusively in uveitis (37.5% vs. 0%; P < 0.01). Conversely, hyporeflective spaces within the IRL were seen only in RVO eyes (42.9% vs. 0%; P = 0.01). No differences were observed in outer retinal hyporeflective spaces (P = 0.23). Quantitatively, eyes with RVO showed greater lumen thickness (median 180 μm [interquartile range: 160-220] vs. 122 μm [118–146]; P < 0.001) and IRL thickness (35 μm [18–79] vs. 28 μm [16–36]; P = 0.04). Outer wall thickness was greater in uveitis (16.5 μm [14.0–20.0] vs. 11.0 μm [9.0–13.8]; P = 0.001), while inner wall thickness did not differ. These findings remained significant in adjusted mixed-effects models. Compared with matched healthy controls, RVO vessels exhibited a larger lumen diameter and superior wall thickness, whereas uveitis vessels showed increased superior and inferior wall thickness without luminal enlargement. Detailed comparisons are reported in Table 2 and Figure 2. Table 2Comparisons of Qualitative and Quantitative High-Resolution OCT Biomarkers among Eyes with RVO, Active Uveitis, and Matched Healthy ControlsRetinal Vein OcclusionUveitisMatched ControlsBaselineRVO vs. UveitisBaselineFollow-UpBL vs. F/UBaselineRVO vs. ControlsUveitis vs. ControlsUnadjusted PAdjusted PUnadjusted PAdjusted PUnadjusted PAdjusted PUnadjusted PAdjusted PQualitative biomarkers Outer wall visibility, n (%)1811614 (100%)1 Wall-splitting sign, n (%)0 (0%)<0.01610.02 Outer fuzziness, n (%)1<0.00117100.65 Inner hyporeflective spaces, n (%)90.0010 (0%)0 (0%)1 Outer hyporeflective spaces, n (%)30.230 (0%)0 (0%)1Quantitative biomarkers Lumen thickness, median (IQR)180.0 (160.0–220.0)<0.0010.002122.0 (118.0–145.5)130.0 (110.5–138.3)0.010.03142.5 (113.0–149.0)<0.001<0.0010.580.58 Inner wall thickness, median (IQR)14.0 (10.0–15.0)0.980.5613.0 (10.5–13.0)9.0 (8.0–10.8)0.030.0210.0 (9.0–11.0)0.0040.010.0060.01 Outer wall thickness, median (IQR)11.0 (9.0–13.8)0.0010.0216.5 (14.0–20.0)8.0 (7.3–10.5)0.0020.00111.0 (9.8–11.3)0.290.29<0.001<0.001 IRL thickness, median (IQR)35.0 (18.0–79.0)0.040.0128.0 (16.0–36.0)20.0 (8.0–28.8)0.004<0.01BL = baseline; F/U = follow-up; IQR = interquartile range; IRL = inner retinal layer; RVO = retinal vein occlusion.Unadjusted P values for RVO vs. uveitis and BL vs. F/U comparisons were derived from Fisher exact test or Mann–Whitney U test for categorical and continuous variables, respectively; adjusted P values from generalized linear mixed-effects models accounting for hierarchical nesting (multiple vessels per eye, both eyes per patient) and adjusted for age, sex, and cardiovascular risk factors. Control comparisons were performed using the Kruskal–Wallis test with Dunn post hoc analysis and Benjamini–Hochberg correction (unadjusted) and generalized linear mixed-effects models (adjusted). Matched healthy controls were selected using propensity score matching based on age, sex, and eye laterality. Comparisons of Qualitative and Quantitative High-Resolution OCT Biomarkers among Eyes with RVO, Active Uveitis, and Matched Healthy Controls BL = baseline; F/U = follow-up; IQR = interquartile range; IRL = inner retinal layer; RVO = retinal vein occlusion. Unadjusted P values for RVO vs. uveitis and BL vs. F/U comparisons were derived from Fisher exact test or Mann–Whitney U test for categorical and continuous variables, respectively; adjusted P values from generalized linear mixed-effects models accounting for hierarchical nesting (multiple vessels per eye, both eyes per patient) and adjusted for age, sex, and cardiovascular risk factors. Control comparisons were performed using the Kruskal–Wallis test with Dunn post hoc analysis and Benjamini–Hochberg correction (unadjusted) and generalized linear mixed-effects models (adjusted). Matched healthy controls were selected using propensity score matching based on age, sex, and eye laterality. Quantitative comparison of retinal venous and perivascular structural biomarkers in RVO, active uveitis, and matched healthy controls. Boxplots showing inner wall thickness (top left), outer wall thickness (top right), inner retinal layer thickness (bottom left), and lumen diameter (bottom right) measured 1000 μm from the optic disc margin. Each dot represents an individual vessel measurement, with horizontal bars indicating medians and boxes representing interquartile ranges. Green, blue, and red indicate RVO, matched healthy controls, and uveitis, respectively. For comparisons among RVO, uveitis, and matched controls, unadjusted P values were derived from the Kruskal–Wallis test with Dunn post hoc analysis and Benjamini–Hochberg correction, while adjusted P values were obtained from generalized linear mixed-effects models accounting for hierarchical nesting (multiple vessels per eye and both eyes per patient) and adjusted for age, sex, and cardiovascular risk factors as covariates. Inner retinal layer thickness—available only for disease groups—was compared between RVO and uveitis using the same approach. Compared with matched controls, RVO vessels demonstrated significantly greater lumen diameter and inner retinal layer thickness, whereas uveitis vessels exhibited significantly thicker outer walls. Inner wall thickness did not differ significantly between RVO and uveitis groups. RVO = retinal vein occlusion. Vascular Changes in Uveitis over Time Follow-up after remission (median 3.1 months [interquartile range: 2.8–3.3]) was available for 14 veins from 8 patients. The wall-splitting sign significantly decreased (P = 0.02), whereas outer fuzziness persisted (P = 0.65). Significant reductions were observed in inner and outer wall thickness (z = –2.34, P = 0.03 and z = –3.74, P = 0.02, respectively), lumen diameter (z = –2.94, P = 0.01), and IRL thickness (z = –3.45, P = 0.004). These longitudinal changes remained significant after adjustment for age, sex, and cardiovascular risk factors in mixed-effects models (β range: –34.2 to –6.43; all P < 0.05). Detailed longitudinal changes are reported in Table 2, Figures 3 and 4. Longitudinal changes in retinal venous and perivascular parameters in uveitis. Paired line plots showing individual (gray) and mean (red) changes in inner wall thickness (top left), outer wall thickness (top right), inner retinal layer thickness (bottom left), and lumen diameter (bottom right) from baseline (Time 0) to 3-month follow-up (Time 1). Significant reductions were observed across all parameters after clinical resolution of uveitis, with the greatest relative decrease seen in outer wall thickness. Additional examples of retinal vein alterations in uveitis with vascular leakage at baseline and follow-up. In the first case (A–F), High-Res OCT (Heidelberg Engineering GmbH) at baseline shows marked wall splitting with heterogeneous hyperreflective material accumulating within and around the vessel (C, red arrowheads), corresponding to venous leakage on FA (B, red arrow). After clinical remission, vessel wall thickness decreases with resolution of the “wall-splitting” sign (F), paralleled by absence of FA leakage (E, yellow arrow). Minimal perivascular outer fuzziness persists (yellow asterisks). In the second case (G–L), baseline High-Res OCT demonstrates a well-demarcated focal wall splitting with hyperreflective material within the vessel wall (I, red arrowheads) associated with intense venous leakage on FA (H, red arrow). At follow-up, the “wall-splitting” sign resolves on High-Res OCT (L), leaving only subtle outer fuzziness adjacent to the vessel (yellow asterisks), while FA shows marked reduction of vascular leakage (K, yellow arrow). FA = fluorescein angiography; High-Res OCT = High-Resolution OCT. Discussion In this prospective, observational study, we used High-Res OCT to characterize retinal venous wall alterations in eyes with vascular leakage secondary to RVO and uveitis. Cross-sectionally, 2 distinct patterns emerged: eyes with RVO showed greater luminal thickness and inner retinal changes, whereas eyes with uveitis exhibited prominent outer wall thickening, perivascular hyperreflective material, and frequent visualization of an apparent wall splitting (“wall-splitting sign”). In the uveitis subgroup with longitudinal follow-up, these structural abnormalities improved markedly after clinical remission, with significant reduction in outer wall thickness and resolution of the wall-splitting sign. Retinal vascular leakage, as visualized on FA, is a hallmark of disease activity and is typically attributed to breakdown of the iBRB—a highly specialized interface formed by nonfenestrated endothelial cells, tight junction proteins (e.g., claudins, occludins), pericytes, and supporting glial elements such as Müller cells and astrocytes.19 The integrity of this barrier can be compromised by a variety of insults, including ischemic, mechanical, or immune-mediated triggers, which lead to increased retinal vascular permeability.2 Although FA remains the reference standard for detecting leakage, it does not allow direct assessment of vessel wall integrity. In this context, High-Res OCT enables in vivo visualization of vascular and perivascular structural changes that may reflect distinct pathogenic mechanisms and offer novel imaging biomarkers for disease characterization and monitoring. In our study, we observed significantly increased lumen and IRL thickness, along with a higher prevalence of inner retinal hyporeflective spaces in the RVO subgroup compared with uveitis. These findings are consistent with the known hemodynamic changes occurring in RVO, including increased intraluminal pressure and fluid extravasation into the IRLs.21,22 Histopathologic studies support this mechanism, demonstrating venous distension, endothelial swelling, and perivascular edema with minimal inflammatory infiltration in acute RVO.23 Importantly, these alterations were also significant when RVO vessels were compared with age-, sex-, and laterality-matched healthy controls, supporting their pathological nature rather than physiological variability. Notably, the absence of significant outer wall changes in RVO eyes further supports that the OCT phenotype observed in this group differs from that seen in active uveitis, suggesting that the inner retina may represent a locus minoris resistentiae for fluid accumulation due to the permissive nature of the internal limiting membrane facilitating early intraretinal fluid entry.24 However, the exact relationship between these imaging features and the direction or compartmentalization of fluid movement within the retina cannot be established from our data alone. In contrast, eyes with uveitis showed significantly greater outer wall thickness and a higher prevalence of the wall-splitting sign compared with both RVO eyes and matched healthy controls, without associated luminal enlargement, supporting a primarily inflammatory pattern of vascular involvement. Described here for the first time, the wall splitting sign may represent a High-Res OCT correlate of a structural separation within the retinal venular wall-perivascular unit. In the absence of direct histopathologic correlation, we hypothesize that this finding reflects imbibition of the vessels wall and adjacent perivascular tissue by fluid, inflammatory proteins, and/or leukocytes, as inflammatory exudation traverses from the intravascular to the extravascular compartment.25,26 This process may involve separation between the endothelial/pericyte complex and the surrounding perivascular glial sheath, rather than between classical vascular layers. However, it has to be acknowledged that—because the precise microscopic substrate of this sign remains unknown—this interpretation should be regarded as tentative. Although outer wall visibility, wall splitting, and outer fuzziness may appear visually related, they likely reflect different—albeit partially overlapping—features of the venous wall-perivascular unit, namely boundary delineation, intramural separation, and extramural hyperreflective change, respectively. Collectively, these findings support a transmural inflammatory process consistent with histologic descriptions of retinal vasculitis, including endothelial disruption and perivascular leukocytic infiltration.27 The preferential involvement of the outer aspect of the vessel wall in uveitis was a reproducible feature in our series. Based on our data, we hypothesize that this pattern reflects preferential extension of inflammatory exudation into the outer venular wall-perivascular unit.28 This is in line with the localization of edema to the outer nuclear layer in neuroretinitis29 and the involvement of the Henle fiber layer in inflammatory choriocapillaropathies (e.g., angular sign of Henle fiber layer hyperreflectivity sign).30 Although our mixed-effects models adjusted for age and cardiovascular risk factors, we cannot exclude that these variables also contributed biologically to the observed findings. In particular, older and potentially less compliant venous walls in RVO and younger veins in uveitis may have differed in their structural response to hydrostatic and inflammatory stress. In our longitudinal analysis, outer wall thickening and vessel wall splitting resolved almost completely after inflammatory remission, whereas outer fuzziness decreased without reaching statistical significance. These findings support our interpretation of the High-Res OCT features as reflecting active inflammatory exudation. At the same time, the persistence of outer fuzziness after remission suggests that not all perivascular hyperreflective changes are necessarily markers of ongoing active inflammation. This residual signal may reflect slower resolution of exudative material or secondary tissue remodeling, as described in hyperviscosity syndromes,31 although this distinction cannot be fully resolved by the present study. Taken together, our findings indicate that High-Res OCT allows in vivo differentiation of 2 distinct patterns of iBRB disruption associated with vascular leakage in RVO and uveitis. In RVO, increased lumen diameter and inner retinal hyporeflective spaces in the absence of significant wall alterations support a predominantly transudative mechanism driven by hydrostatic pressure. In contrast, the transmural changes, outer wall thickening, and iso/hyperreflective perivascular alterations observed in uveitis are consistent with a more profound inflammatory breakdown of vascular integrity, allowing deposition of protein- and cell-rich exudate. It is important to note that wall abnormalities in uveitis were not limited to the outer wall, as inner wall thickness was also increased relative to controls; however, outer wall and perivascular changes represented the more prominent and distinctive pattern in uveitis. These distinctions should be interpreted as imaging correlates of different disease settings rather than as definitive proof of specific fluid or cellular pathways. Future studies comparing different vasculopathies will be necessary to validate their specificity and clarify the underlying structural basis (Fig 5). Schematic representation of the presumed pathogenesis of retinal vascular leakage in RVO and active uveitis. (A) Normal retinal vein showing the 3 principal wall layers—endothelium, tunica media, and tunica adventitia—with preserved integrity of the inner (iBRB) and outer vascular interfaces. (B) In RVO, increased intraluminal hydrostatic pressure leads to venous distension and transudation of fluid into the inner retina through loci minoris resistentiae, resulting in intraretinal edema without significant outer wall disruption. (C) In active uveitis, immune-mediated inflammation compromises vascular wall integrity, causing transmural leakage of protein-rich exudate and inflammatory cells. This process may lead to focal wall splitting, thickening, and to perivascular exudation. (D) During remission, vascular integrity is largely restored, with resolution of the wall splitting and exudation. A residual outer hyperreflective component may persist, likely reflecting delayed resorption of inflammatory material or localized gliosis. iBRB = inner blood-retinal barrier; RVO = retinal vein occlusion. Several limitations warrant consideration. First, the sample size was modest, particularly in the uveitis subgroup, reflecting both the relative rarity of uveitis and the requirement for demonstrable venous leakage in the absence of media opacities suitable for high-quality imaging. Second, although leakage may be segmental, we prioritized standardized measurements within FA-positive vessels to improve reproducibility; this approach may not always capture the single most intensely leaking subsegment, but it reduces positional variability and improves comparability. Differences in disease duration and the predominance of specific inflammatory etiologies within the uveitis subgroup may have influenced the observed OCT morphology and may limit generalizability to all retinal inflammatory venous processes. Although longitudinal analysis was feasible in uveitis eyes, follow-up duration was limited, and serial assessment was not possible in RVO due to dynamic posttreatment venous remodeling that precluded reliable reidentification of the same vascular segments. Additionally, although grading was performed independently and masked to the formal diagnosis, some surrounding retinal changes may have made complete inferential masking difficult. Similarly, despite standardized longitudinal acquisition and scan selection, minor off-axis sectioning cannot be fully excluded. Interpretation of novel findings—most notably the wall-splitting sign—remains speculative without histopathologic validation, which will be essential to confirm their anatomical substrate. Because the study was designed for characterizing FA-leaking veins rather than comparing them with nonleaking segments, the diagnostic performance of High-Res OCT signs for detecting FA leakage could not be assessed. Finally, volumetric assessment of perivascular changes and correlation with other high-resolution imaging modalities, such as adaptive optics, were beyond the scope of this study and merit future investigation. In conclusion, High-Res OCT enabled in vivo differentiation of 2 distinct patterns of venous wall alterations associated with retinal vascular leakage in RVO and uveitis. Retinal vein occlusion was characterized by inner retinal hyporeflective changes and luminal distension consistent with a pressure-driven transudative process, whereas uveitic leakage showed transmural involvement with outer wall thickening, outer fuzziness, and the novel wall-splitting sign—features suggestive of inflammatory exudation and vessel wall infiltration. These findings highlight the value of high-resolution imaging in refining structural assessment of iBRB disruption and in providing clinically meaningful biomarkers for retinal vascular and inflammatory diseases. Manuscript no. XOPS-D-26-00039. Footnotes Supplemental material available atwww.ophthalmologyscience.org. Disclosure(s): The Article Publishing Charge (APC) for this article was paid by Department of Biomedical and Clinical Sciences of Ospedale Luigi Sacco, University of Milan. All authors have completed and submitted the ICMJE disclosures form. The author(s) have made the following disclosure(s): F.R.: Royalties or licenses – Coinventor on a patent through Massachusetts Eye and Ear (U.S. 63/381,925); Travel expenses – Roche. M.C.: Travel expenses – Bayer HealthCare, Nidek, Novartis, Heidelberg Engineering, and Zeiss. S.S.: Consultant – Apellis, Alkeus, Aavantgarde, ONL therapeutics, Amgen, Abbvie/Allergan, Alexion, Alnylam, Samsung Bioepis, Biogen, Boerhinger Ingelheim, IvericBio/Astellas, iCare/ Centervue, Eyepoint, Novartis, Roche/Genentech, Bayer, Regeneron, Pfizer, Nanoscope, Jannsen, Optos, OysterPoint, Heidelberg, Ikerian, NotalVision, Topcon, Eyepoint, Character, Ocular Therapeutics, Neurotech]; Honoraria – Novartis, Roche, Optos, Heidelberg, Nidek; Travel expenses – Optos, Samsung Biopeis, Roche, Heidelberg Engineering, Apellis, Abbvie, Novartis; Participation on a Data Safety Monitoring Board or Advisory Board – Regeneron, RegenxBio; Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid – ARVO, Macula Society, IntRIS; Receipt of equipment, materials, drugs, medical writing, gifts or other services – iCare, Carl Zeiss Meditec, Optos, Nidek, Topcon, Heidelberg, Intalight; Other financial or nonfinancial interests – Coherus Biosciences. L.C.: AbbVie, Sifi, Optos. G.S.: Consultant – Heidelberg Engineering, Optos, OptoVue, CenterVue, Allergan, Bayer, Genetech, Novartis, Quantel Medical, Carl Zeiss Meditec, Boheringer, Topcon, Roche. A.I.: Consultant – Novartis, Bayer, Roche; Honoraria – Heidelberg Engineering, AbbVie. David Sarraf, MD and SriniVas Sadda, MD, editorial board members of this journal, were recused from the peer-review process of this article and had no access to information regarding its peer-review. HUMAN SUBJECTS: Human subjects were included in this study. This prospective, observational, cross-sectional and longitudinal study was conducted at the Eye Clinic of Ospedale Luigi Sacco (University of Milan, Milan, Italy) between January and November 2024. The study adhered to the Declaration of Helsinki and Italian bioethics regulations and was approved by the Institutional Ethics Committee of the University of Milan (Protocol No. 19.22). Written informed consent was obtained from all participants. No animal subjects were used in this study. Author Contributions: Conception and design: Invernizzi Analysis and interpretation: Romano, Sarraf, Sadda, Gupta, El Asrar, Cimino, Staurenghi, Invernizzi Data collection: Romano, Lamanna, Cozzi, Cutrupi, Surico, Invernizzi Obtained funding: N/A Overall responsibility: Romano, Invernizzi Supplementary Data Supplementary Figure S1 References Associated Data Supplementary Materials Supplementary Figure S1